Murat Gençaslan
Murat Gençaslan has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Fadime Koca
Department of Cardiology, Cukurova State Hospital, 01230 Adana, Turkey
3 shared publications - Ömer Bedir
Adana City Training and Research Hospital
3 shared publications - Ceyhun Yucel
Department of Cardiology, University of Health Sciences–Adana Health Practice and Research Center, Dr. Mithat Özsan Bulvarı Kışla Mah. 4522 Sok. No: 1 Yüreğir, 01230 Adana, Turkey
2 shared publications - Ceyhun Yucel
Adana City Training and Research Hospital
2 shared publications - Emre Sezici
Department of Cardiology, University of Health Sciences, Adana Health Practice and Research Center, 01230 Adana, Turkey
2 shared publications - Hilmi Erdem Sumbul
Department of Internal Medicine, University of Health Sciences, Adana City Training and Research Hospital, Adana, Turkey
2 shared publications
Latest Publications
- Open Access
- 20 November 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (11) , 614
The Index of Cardio-Electrophysiological Balance Is Associated with Malignant Ventricular Arrhythmia and New-Onset Atrial Fibrillation in STEMI Patients
Introduction: The index of cardio-electrophysiological balance (iCEB) has been associated with various cardiac arrhythmias. However, the relationship between iCEB and ventricular arrhythmias (VA) as well as atrial fibrillation (AF) in patients with ST-segment elevation myocardial infarction (STEMI) remains unclear. In this study, we aimed to evaluate the association between iCEB and the development of malignant VA and new-onset AF in patients with STEMI. Method: A total of 250 patients presenting with STEMI (49 females, 201 males; mean age 59.3 ± 12.5 years) were included in this retrospective observational cohort study. A standard 12-lead electrocardiogram (ECG) was obtained from all patients at the time of hospital admission. In addition to routine ECG parameters, iCEB (QT/QRS) was calculated from the recorded ECGs. Patients were monitored for the occurrence of malignant VA (sustained ventricular tachycardia and ventricular fibrillation) and new-onset AF within the first 48 h. The study population was divided into groups based on the presence or absence of malignant VA and new-onset AF, and all parameters were compared between these groups. Results: QT interval, QTc interval, JT interval, iCEB, and iCEBc values were found to be significantly higher in patients with malignant VA compared to those without malignant VA. Similarly, QT interval, QTc interval, JT interval, iCEB, and iCEBc values were significantly elevated in patients with new-onset AF compared to those without new-onset AF. In logistic regression analysis, iCEB and JT interval were identified as independent predictors of malignant VA (OR = 1.051, 95% CI: 1.015–1.132, p = 0.016 and OR = 1.013, 95% CI: 1.003–1.025, p = 0.013, respectively). Likewise, iCEB and JT interval were also independent predictors of new-onset AF (OR = 1.099, 95% CI: 1.033–1.169, p = 0.003 and OR = 1.018, 95% CI: 1.006–1.030, p = 0.002, respectively). Discussion: In our study, iCEB measured at the time of admission in patients with STEMI was shown to be a significant adjunctive parameter in identifying both malignant VA and new-onset AF. Therefore, STEMI patients with elevated iCEB values should be closely monitored for the development of arrhythmias.
- 20 November 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (11) , 614
Open AccessThe Index of Cardio-Electrophysiological Balance Is Associated with Malignant Ventricular Arrhythmia and New-Onset Atrial Fibrillation in STEMI Patients
Introduction: The index of cardio-electrophysiological balance (iCEB) has been associated with various cardiac arrhythmias. However, the relationship between iCEB and ventricular arrhythmias (VA) as well as atrial fibrillation (AF) in patients with ST-segment elevation myocardial infarction (STEMI) remains unclear. In this study, we aimed to evaluate the association between iCEB and the development of malignant VA and new-onset AF in patients with STEMI. Method: A total of 250 patients presenting with STEMI (49 females, 201 males; mean age 59.3 ± 12.5 years) were included in this retrospective observational cohort study. A standard 12-lead electrocardiogram (ECG) was obtained from all patients at the time of hospital admission. In addition to routine ECG parameters, iCEB (QT/QRS) was calculated from the recorded ECGs. Patients were monitored for the occurrence of malignant VA (sustained ventricular tachycardia and ventricular fibrillation) and new-onset AF within the first 48 h. The study population was divided into groups based on the presence or absence of malignant VA and new-onset AF, and all parameters were compared between these groups. Results: QT interval, QTc interval, JT interval, iCEB, and iCEBc values were found to be significantly higher in patients with malignant VA compared to those without malignant VA. Similarly, QT interval, QTc interval, JT interval, iCEB, and iCEBc values were significantly elevated in patients with new-onset AF compared to those without new-onset AF. In logistic regression analysis, iCEB and JT interval were identified as independent predictors of malignant VA (OR = 1.051, 95% CI: 1.015–1.132, p = 0.016 and OR = 1.013, 95% CI: 1.003–1.025, p = 0.013, respectively). Likewise, iCEB and JT interval were also independent predictors of new-onset AF (OR = 1.099, 95% CI: 1.033–1.169, p = 0.003 and OR = 1.018, 95% CI: 1.006–1.030, p = 0.002, respectively). Discussion: In our study, iCEB measured at the time of admission in patients with STEMI was shown to be a significant adjunctive parameter in identifying both malignant VA and new-onset AF. Therefore, STEMI patients with elevated iCEB values should be closely monitored for the development of arrhythmias.
- Open Access
- 30 September 2026
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 51 (3) , 1026-1038
Geriatric Nutritional Risk Index and in-hospital adverse events in patients with ST-segment elevation myocardial infarction
Purpose: Malnutrition and inflammation are common in ST-segment elevation myocardial infarction and may influence early vulnerability. We evaluated whether the admission Geriatric Nutritional Risk Index is associated with in-hospital adverse events, and compared it with the Prognostic Nutritional Index and the Controlling Nutritional Status score.Materials and Methods: This retrospective observational study included 748 consecutive adults with the infarction treated between January 2024 and December 2025. The nutritional index was calculated from admission albumin, weight, height, and sex. The primary endpoint was a composite of in-hospital ventricular tachycardia or fibrillation, intubation, death, contrast-associated acute kidney injury, cardiogenic shock, intra-aortic balloon pump, or cardiopulmonary resuscitation; a prespecified nonrenal composite was a sensitivity endpoint. The index was modeled continuously per 10-point lower value with logistic regression and bootstrap internal validation.Results: The primary endpoint occurred in 141 of 748 patients (18.9%). Median GNRI was 98.3 (interquartile range, 95.3–102.0). Each 10-point lower GNRI was associated with the primary endpoint before adjustment (odds ratio 1.61, 95% confidence interval 1.13–2.28) and after demographic and comorbidity adjustment (1.57, 1.10–2.23). The association was attenuated after additional adjustment for acute severity (0.99, 0.66–1.49), with a similar pattern for the nonrenal composite. The areas under the receiver-operating characteristic curve were 0.579 for GNRI, 0.564 for CONUT, and 0.457 for PNI.Conclusion: A lower admission index was associated with a higher risk of in-hospital mortality; however, this association was attenuated after accounting for acute illness severity. As a simple and readily available nutritional marker at admission, the index should be used as an indicator of overall frailty rather than as a standalone decision-making tool.
- 30 September 2026
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 51 (3) , 1026-1038
Open AccessGeriatric Nutritional Risk Index and in-hospital adverse events in patients with ST-segment elevation myocardial infarction
Purpose: Malnutrition and inflammation are common in ST-segment elevation myocardial infarction and may influence early vulnerability. We evaluated whether the admission Geriatric Nutritional Risk Index is associated with in-hospital adverse events, and compared it with the Prognostic Nutritional Index and the Controlling Nutritional Status score.Materials and Methods: This retrospective observational study included 748 consecutive adults with the infarction treated between January 2024 and December 2025. The nutritional index was calculated from admission albumin, weight, height, and sex. The primary endpoint was a composite of in-hospital ventricular tachycardia or fibrillation, intubation, death, contrast-associated acute kidney injury, cardiogenic shock, intra-aortic balloon pump, or cardiopulmonary resuscitation; a prespecified nonrenal composite was a sensitivity endpoint. The index was modeled continuously per 10-point lower value with logistic regression and bootstrap internal validation.Results: The primary endpoint occurred in 141 of 748 patients (18.9%). Median GNRI was 98.3 (interquartile range, 95.3–102.0). Each 10-point lower GNRI was associated with the primary endpoint before adjustment (odds ratio 1.61, 95% confidence interval 1.13–2.28) and after demographic and comorbidity adjustment (1.57, 1.10–2.23). The association was attenuated after additional adjustment for acute severity (0.99, 0.66–1.49), with a similar pattern for the nonrenal composite. The areas under the receiver-operating characteristic curve were 0.579 for GNRI, 0.564 for CONUT, and 0.457 for PNI.Conclusion: A lower admission index was associated with a higher risk of in-hospital mortality; however, this association was attenuated after accounting for acute illness severity. As a simple and readily available nutritional marker at admission, the index should be used as an indicator of overall frailty rather than as a standalone decision-making tool.
- 9 September 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Increased Cardiovascular Hospitalizations Associated With Presence of Atrial Fibrillation in Acute Coronary Syndrome Patients: A Double Trouble Situation
Background: In previous studies, atrial fibrillation (AF) has been reported to be common among patients with acute coronary syndrome (ACS), and the presence of AF has been associated with increased mortality and morbidity. However, treatment strategies for both ACS and AF have been continuously updated. Aims: The aim of the present study was to determine the prevalence of AF in ACS patients treated according to the most recent guideline recommendations and to evaluate the prognostic significance of AF in this population. Methods: In this retrospective cohort study, 285 patients diagnosed with and treated for ACS between 2024 and 2025 were included. The prevalence of AF was determined in this cohort. All patients were followed for at least 1‐year. The study endpoint was the occurrence of cardiovascular (CV) mortality and CV‐related hospitalizations. Results: AF was identified in 79 patients (28%) with ACS. The mean follow‐up duration was 16.5 ± 7.4 months. During follow‐up, CV mortality occurred in 37 patients (13%), and CV‐related hospitalizations were observed in 97 patients (34%). In regression analysis, left atrial (LA) dimension and smoking status were independently associated with the presence of AF (OR = 1.264, 95% CI: 1.164–1.372, p < 0.001 and OR = 2.318, 95% CI: 1.251–4.295, p = 0.008, respectively). Left ventricular ejection fraction and LA dimension were independently associated with CV mortality (HR = 0.964, 95% CI: 0.936–0.992, p = 0.014 and HR = 1.080, 95% CI: 1.012–1.152, p = 0.020, respectively). In addition, the presence of AF and hypertension were independently associated with CV‐related hospitalizations (HR = 1.564, 95% CI: 1.091–2.240, p = 0.015; and HR = 1.686, 95% CI: 1.246–2.240, p = 0.001, respectively). Conclusion: Although the presence of AF in patients with ACS was not independently associated with CV mortality, it was independently associated with CV‐related hospitalizations despite contemporary treatment strategies. Therefore, closer follow‐up and more intensive management of ACS patients with AF may be necessary to reduce the frequency of CV‐related hospitalizations.
- 9 September 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Increased Cardiovascular Hospitalizations Associated With Presence of Atrial Fibrillation in Acute Coronary Syndrome Patients: A Double Trouble Situation
Background: In previous studies, atrial fibrillation (AF) has been reported to be common among patients with acute coronary syndrome (ACS), and the presence of AF has been associated with increased mortality and morbidity. However, treatment strategies for both ACS and AF have been continuously updated. Aims: The aim of the present study was to determine the prevalence of AF in ACS patients treated according to the most recent guideline recommendations and to evaluate the prognostic significance of AF in this population. Methods: In this retrospective cohort study, 285 patients diagnosed with and treated for ACS between 2024 and 2025 were included. The prevalence of AF was determined in this cohort. All patients were followed for at least 1‐year. The study endpoint was the occurrence of cardiovascular (CV) mortality and CV‐related hospitalizations. Results: AF was identified in 79 patients (28%) with ACS. The mean follow‐up duration was 16.5 ± 7.4 months. During follow‐up, CV mortality occurred in 37 patients (13%), and CV‐related hospitalizations were observed in 97 patients (34%). In regression analysis, left atrial (LA) dimension and smoking status were independently associated with the presence of AF (OR = 1.264, 95% CI: 1.164–1.372, p < 0.001 and OR = 2.318, 95% CI: 1.251–4.295, p = 0.008, respectively). Left ventricular ejection fraction and LA dimension were independently associated with CV mortality (HR = 0.964, 95% CI: 0.936–0.992, p = 0.014 and HR = 1.080, 95% CI: 1.012–1.152, p = 0.020, respectively). In addition, the presence of AF and hypertension were independently associated with CV‐related hospitalizations (HR = 1.564, 95% CI: 1.091–2.240, p = 0.015; and HR = 1.686, 95% CI: 1.246–2.240, p = 0.001, respectively). Conclusion: Although the presence of AF in patients with ACS was not independently associated with CV mortality, it was independently associated with CV‐related hospitalizations despite contemporary treatment strategies. Therefore, closer follow‐up and more intensive management of ACS patients with AF may be necessary to reduce the frequency of CV‐related hospitalizations.
- Open Access
Prognostic Value of Conventional and Modified Naples Scores for In-Hospital Mortality in Patients with Non-ST-Elevation Acute Coronary Syndrome
Background and Objectives: Inflammation and nutritional status are closely associated with prognosis in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS). This study compared the prognostic performance of the conventional Naples score and CRP-modified Naples score for predicting in-hospital mortality. Materials and Methods: This retrospective, single-center study included 921 patients with NSTE-ACS undergoing percutaneous coronary intervention. Multivariable logistic regression, ROC analysis, reclassification indices, restricted cubic spline analysis, and decision curve analysis were performed. Results: In-hospital mortality occurred in 79 patients (8.6%). Patients who died had higher Naples score and modified Naples score values than survivors. In multivariable models adjusted for baseline clinical variables and GRACE score, both the modified Naples score and conventional Naples score remained independently associated with in-hospital mortality. The modified Naples score showed an adjusted-OR of 3.85 (95% CI: 2.71–5.48; p < 0.001), whereas the conventional Naples score showed an adjusted-OR of 4.52 (95% CI: 3.05–6.70; p < 0.001). The addition of the modified Naples score improved model performance, with a C-index of 0.819, NRI of 0.741, and IDI of 0.127. Similarly, the conventional Naples score model showed a C-index of 0.827, NRI of 0.843, and IDI of 0.125. In ROC analysis, the AUC was 0.701 for the modified Naples score and 0.683 for the conventional Naples score, without a statistically significant difference between them (ΔAUC = 0.017; p = 0.300). Decision curve analysis showed positive net clinical benefit for both scores, with no consistent superiority of either score. Conclusions: Both Naples-based scores were independently associated with in-hospital mortality and provided comparable prognostic performance in patients with NSTE-ACS undergoing PCI.
Open AccessPrognostic Value of Conventional and Modified Naples Scores for In-Hospital Mortality in Patients with Non-ST-Elevation Acute Coronary Syndrome
Background and Objectives: Inflammation and nutritional status are closely associated with prognosis in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS). This study compared the prognostic performance of the conventional Naples score and CRP-modified Naples score for predicting in-hospital mortality. Materials and Methods: This retrospective, single-center study included 921 patients with NSTE-ACS undergoing percutaneous coronary intervention. Multivariable logistic regression, ROC analysis, reclassification indices, restricted cubic spline analysis, and decision curve analysis were performed. Results: In-hospital mortality occurred in 79 patients (8.6%). Patients who died had higher Naples score and modified Naples score values than survivors. In multivariable models adjusted for baseline clinical variables and GRACE score, both the modified Naples score and conventional Naples score remained independently associated with in-hospital mortality. The modified Naples score showed an adjusted-OR of 3.85 (95% CI: 2.71–5.48; p < 0.001), whereas the conventional Naples score showed an adjusted-OR of 4.52 (95% CI: 3.05–6.70; p < 0.001). The addition of the modified Naples score improved model performance, with a C-index of 0.819, NRI of 0.741, and IDI of 0.127. Similarly, the conventional Naples score model showed a C-index of 0.827, NRI of 0.843, and IDI of 0.125. In ROC analysis, the AUC was 0.701 for the modified Naples score and 0.683 for the conventional Naples score, without a statistically significant difference between them (ΔAUC = 0.017; p = 0.300). Decision curve analysis showed positive net clinical benefit for both scores, with no consistent superiority of either score. Conclusions: Both Naples-based scores were independently associated with in-hospital mortality and provided comparable prognostic performance in patients with NSTE-ACS undergoing PCI.
- Open Access
- 31 January 2026
- Published by Tıp Fakültesi, Karadeniz Teknik Üniversitesi in Farabi Tıp Dergisi
- Vol. 5 (1) , 1-20
Fluoroquinolone Exposure and Coronary Artery Ectasia: A Retrospective Angiography-Based Case-Control Study
Objective: Fluoroquinolones have been linked to collagen-related adverse events and aortic aneurysm or dissection, but their relationship with coronary artery ectasia (CAE) is unknown. We evaluated whether documented systemic fluoroquinolone exposure was associated with angiographically defined CAE and with CAE anatomic phenotype. Material and Methods: In this retrospective case-control study, 530 adults undergoing coronary angiography between January 2023 and May 2024 were included: 267 with CAE and 263 angiographic controls. The exposure was documented systemic fluoroquinolone use before angiography, ascertained from institutional prescribing and medication records. Logistic regression estimated odds ratios (ORs) and 95% confidence intervals (CIs) with sequential adjustment for demographics, cardiovascular risk factors, angiographic indication, and other antibiotic and non-steroidal anti-inflammatory drug exposure. Cumulative dose, active-comparator, overlap-weighted, and case-only analyses were supportive. Results: Fluoroquinolone exposure was present in 152 of 267 cases (56.9%) and 71 of 263 controls (27.0%). The unadjusted OR was 3.57, 95% CI [2.48, 5.15]; the association persisted after adjustment for measured clinical and medication covariates, OR = 3.83, 95% CI [2.61, 5.62], p < .001. Among 223 exposed participants, an exploratory dose trend was detected (adjusted OR per category = 2.55, 95% CI [1.66, 3.91], p < .001). Findings were consistent in active-comparator and overlap-weighted analyses. Among cases, no statistically significant association with multivessel or diffuse Markis type I/II CAE was detected. Conclusion: Documented fluoroquinolone exposure was associated with CAE after adjustment for measured covariates; no statistically significant association with angiographic extent was detected among CAE cases. These findings are hypothesis-generating and require confirmation in multicenter, pharmacy-linked studies.
- 31 January 2026
- Published by Tıp Fakültesi, Karadeniz Teknik Üniversitesi in Farabi Tıp Dergisi
- Vol. 5 (1) , 1-20
Open AccessFluoroquinolone Exposure and Coronary Artery Ectasia: A Retrospective Angiography-Based Case-Control Study
Objective: Fluoroquinolones have been linked to collagen-related adverse events and aortic aneurysm or dissection, but their relationship with coronary artery ectasia (CAE) is unknown. We evaluated whether documented systemic fluoroquinolone exposure was associated with angiographically defined CAE and with CAE anatomic phenotype. Material and Methods: In this retrospective case-control study, 530 adults undergoing coronary angiography between January 2023 and May 2024 were included: 267 with CAE and 263 angiographic controls. The exposure was documented systemic fluoroquinolone use before angiography, ascertained from institutional prescribing and medication records. Logistic regression estimated odds ratios (ORs) and 95% confidence intervals (CIs) with sequential adjustment for demographics, cardiovascular risk factors, angiographic indication, and other antibiotic and non-steroidal anti-inflammatory drug exposure. Cumulative dose, active-comparator, overlap-weighted, and case-only analyses were supportive. Results: Fluoroquinolone exposure was present in 152 of 267 cases (56.9%) and 71 of 263 controls (27.0%). The unadjusted OR was 3.57, 95% CI [2.48, 5.15]; the association persisted after adjustment for measured clinical and medication covariates, OR = 3.83, 95% CI [2.61, 5.62], p < .001. Among 223 exposed participants, an exploratory dose trend was detected (adjusted OR per category = 2.55, 95% CI [1.66, 3.91], p < .001). Findings were consistent in active-comparator and overlap-weighted analyses. Among cases, no statistically significant association with multivessel or diffuse Markis type I/II CAE was detected. Conclusion: Documented fluoroquinolone exposure was associated with CAE after adjustment for measured covariates; no statistically significant association with angiographic extent was detected among CAE cases. These findings are hypothesis-generating and require confirmation in multicenter, pharmacy-linked studies.